{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T19:18:04Z","timestamp":1784575084957,"version":"3.55.0"},"reference-count":9,"publisher":"Georg Thieme Verlag KG","issue":"S 01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Perinatol"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:p>\n            Objective\u2003Hypertensive disorders of pregnancy (HDP) impact 10% of pregnancies in the United States and cause adverse maternal and neonatal outcomes such as prematurity and low birth weight. Aspirin administration to at-risk individuals during pregnancy can reduce risk of HDP.<\/jats:p><jats:p>\n            Study Design\u2003Define-Measure-Assess-Improve-Control methodology was utilized to improve aspirin screening in an outpatient obstetric clinic. Retrospective cohort analysis compared outcome metrics pre- and postimplementation by using logistic regression models, adjusting for race and insurance. Key informant interviews and process mapping identified barriers to aspirin screening. A multidisciplinary team implemented low-cost strategies such as provider education, additional screening by ancillary staff, automated electronic reminders, and standardized patient counseling.<\/jats:p><jats:p>\n            Results\u2003Over 6 months, the screening rate improved from 62.5 to 92.0% (adjusted odds ratio [aOR]\u2009=\u20096.89, 95% confidence interval [CI]: 3.30\u201314.43). The prescription rate for patients correctly identified to be eligible for aspirin improved from 66.7 to 82.4% (aOR\u2009=\u20091.96, 95% CI: 0.88\u20134.35).<\/jats:p><jats:p>\n            Conclusion\u2003Comprehensive, tailored quality improvement efforts can significantly increase aspirin screening and prescription, which may decrease maternal and neonatal morbidity due to HDP.<\/jats:p><jats:p>\n            Key Points\n          <\/jats:p>","DOI":"10.1055\/s-0042-1759705","type":"journal-article","created":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T23:48:06Z","timestamp":1672444086000},"page":"e917-e921","source":"Crossref","is-referenced-by-count":6,"special_numbering":"S","title":["Quality Improvement Initiative for Aspirin Screening and Prescription Rates for Preeclampsia Prevention in an Outpatient Obstetric Clinic"],"prefix":"10.1055","volume":"41","author":[{"given":"Natasha R.","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedona E.","family":"Speedy","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, Biostatistics Collaboration Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah J.","family":"Welty","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, Biostatistics Collaboration Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjeme D.","family":"Cavens","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2022,12,30]]},"reference":[{"issue":"03","key":"ref1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/hr.2016.126","article-title":"Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis","volume":"40","author":"M Umesawa","year":"2017","journal-title":"Hypertens Res"},{"issue":"18","key":"ref2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.15585\/mmwr.mm6818e1","article-title":"Vital signs: pregnancy-related deaths, United States, 2011\u20132015, and strategies for prevention, 13 states, 2013\u20132017","volume":"68","author":"E E Petersen","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"01","key":"ref3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/AOG.0000000000002372","article-title":"Timing and risk factors of postpartum stroke","volume":"131","author":"G Too","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"16","key":"ref4","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1136\/heartjnl-2018-313453","article-title":"Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy","volume":"105","author":"L Benschop","year":"2019","journal-title":"Heart"},{"issue":"03","key":"ref5","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/HJH.0000000000001594","article-title":"Hypertensive disorders of pregnancy and postpartum readmission in the United States: national surveillance of the revolving door","volume":"36","author":"M F Mogos","year":"2018","journal-title":"J Hypertens"},{"issue":"03","key":"ref6","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0002-9378(98)70439-9","article-title":"The preterm prediction study: risk factors for indicated preterm births","volume":"178","author":"P J Meis","year":"1998","journal-title":"Am J Obstet Gynecol"},{"issue":"06","key":"ref7","first-page":"950","article-title":"Preeclampsia and fetal growth","volume":"96","author":"R A Odeg\u00e5rd","year":"2000","journal-title":"Obstet Gynecol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0002-9378(12)90917-5","article-title":"Low-dose aspirin in the prevention of preeclampsia and fetal growth retardation: rationale, mechanisms, and clinical trials","volume":"168","author":"G A Dekker","year":"1993","journal-title":"Am J Obstet Gynecol"},{"issue":"03","key":"ref9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajog.2017.11.561","article-title":"Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis","volume":"218","author":"S Roberge","year":"2018","journal-title":"Am J Obstet Gynecol"}],"container-title":["American Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0042-1759705.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T13:17:49Z","timestamp":1730812669000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0042-1759705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,30]]},"references-count":9,"journal-issue":{"issue":"S 01","published-online":{"date-parts":[[2024,5,13]]},"published-print":{"date-parts":[[2024,5]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0042-1759705","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0735-1631","1098-8785"],"issn-type":[{"value":"0735-1631","type":"print"},{"value":"1098-8785","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,30]]}}}